Private investment firm Ardian is to acquire a majority stake in the Inula Group, a Belgium-based key player in the herbal remedies market, from Vendis Capital, Dominique Baudoux (Founder & Chairman) and Sergio Calandri (CEO).
The amount of the deal was not disclosed.
Created following the merger of Pranarôm and HerbalGem, two laboratories specializing in natural therapies, founded in 1985 and 1986, respectively, Inula Group is a key player in the herbal remedies market, specializing in sub-sectors such as aromatherapy, gemmotherapy and Bach flowers, through three brands. They are:
– Pranarôm, a leader in scientific aromatherapy (essential oils),
– HerbalGem, a leader in concentrated gemmotherapy (bud extracts), and
– Biofloral, a leader in Bach flowers (floral extracts).
The group is now present in more than 25 countries, with leading positions in France, Belgium, Spain, Italy and the USA, with consolidated sales of €85 million in 2017. The products are distributed by more than 12,000 customers, including pharmacies, natural stores and health professionals. The group has its own organic plant cultures, as well as 4 production laboratories in Belgium (Pranarôm site in Ghislenghien and HerbalGem site in Vielsalm), France (Biofloral site in Auvergne) and the USA (Inula site in Minneapolis).